Abstract: A tire with a built-in antenna includes a radio wave transmissive resin filled in the tire and an antenna arranged in the radio wave transmissive resin, and the antenna transmits a radar wave when an antenna surface of the tire facing a radiation surface of the antenna comes into contact with a ground surface.

Abstract: A water electrolysis system includes: a water electrolyzer configured to electrolyze water to generate gas including oxygen and hydrogen; a gas-liquid separator configured to separate gas phase including hydrogen from liquid phase of the gas generated by the water electrolyzer; a water level detector configured to detect a water level in the gas-liquid separator; a pressure detector configured to detect a pressure of the gas phase in the gas-liquid separator; and a CPU and a memory coupled to the CPU. The CPU is configured to perform: calculating an error of the water level in the gas-liquid separator detected by the water level detector based on the pressure of the gas phase in the gas-liquid separator detected by the pressure detector.

Abstract: Heat-expandable microspheres which have a blowing agent encapsulated efficiently therein so as to prevent the blowing agent from escaping out of the microspheres during storage at high temperature, a process for producing the same, and applications thereof.

Abstract: A hydrogen station includes a state management apparatus that is connected to each of a plurality of systems and manages the states of the plurality of systems, and a safety control apparatus that is formed separately from the main equipment and is connected to the state management apparatus. The state management apparatus performs first watchdog control to check operations of the plurality of systems and the safety control apparatus performs second watchdog control to check an operation of the state management apparatus. The state management apparatus or the safety control apparatus cuts off the power supply from the safety control apparatus to the main equipment if an abnormality is recognized by the second watchdog control, even if the first watchdog control indicates correct operation.

Abstract: A water electrolysis system includes: a water electrolyzer configured to electrolyze water to generate gas including oxygen and hydrogen; a gas-liquid separator configured to separate gas phase including hydrogen from liquid phase of the gas generated by the water electrolyzer; a water level detector configured to detect a water level in the gas-liquid separator; a pressure detector configured to detect a pressure of the gas phase in the gas-liquid separator; and a CPU and a memory coupled to the CPU. The CPU is configured to perform: calculating an error of the water level in the gas-liquid separator detected by the water level detector based on the pressure of the gas phase in the gas-liquid separator detected by the pressure detector.

Abstract: A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases

Abstract: A wire rope formed from a resin core and six strands, the resin core having an inner core with a circular cross section and an outer layer built up on the periphery thereof. The outer layer has a melting temperature lower than that of the inner core. The six strands are twisted together helically on the periphery of the resin core in an intertwining die in such a state that gaps are assured between the strands. The resulting wire rope is heated in a heating unit at a temperature higher than the melting temperature of the outer layer but lower than the melting temperature of the inner core. The wire rope is formed by subsequently compressing the six strands from the periphery thereof in a compressing die. The molten outer layer is hardened by natural cooling, after which the wire rope is taken up.

Abstract: The present invention provides a drug containing a compound having Trk-inhibiting activity as an active ingredient in prophylaxis and/or therapy for Trk-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease. A compound represented by the general formula (I), wherein all symbols represent the same meanings as described in the specification, a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof is useful as a drug component having Trk-inhibiting activity in prophylaxis and/or therapy of diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease.

Abstract: A water electrolysis system is equipped with a water electrolysis device, a water supply passage, a hydrogen supply passage, a gas-liquid separator, a first water drainage passage, a first water drainage valve, a second water drainage valve, a determination unit, and a valve control unit. In a method of stopping operation of the water electrolysis system, in a water drainage step, in the case that the determination unit determines that operation of the water electrolysis device has been stopped, the first water drainage valve is controlled to be placed in a valve open state, thereby draining liquid water from the gas-liquid separator into the first water drainage passage.

Abstract: A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases

Abstract: In a water electrolysis system and a method of controlling the water electrolysis system, a control device places a high pressure water discharge solenoid valve, a depressurizing solenoid valve, and a low pressure water discharge solenoid valve in the closed state. Further, a pressure acquisition unit obtains the electrolysis time pressure as a pressure in the low pressure water sealing container during production of hydrogen by a water electrolyzer. Further, the control device determines the occurrence of hydrogen leakage in a depressurizing line based on at least the electrolysis time pressure.

Abstract: A hydrogen station includes a state management apparatus that is connected to each of a plurality of systems and manages the states of the plurality of systems, and a safety control apparatus that is formed separately from the main equipment and is connected to the state management apparatus. The state management apparatus performs first watchdog control to check operations of the plurality of systems and the safety control apparatus performs second watchdog control to check an operation of the state management apparatus. The state management apparatus or the safety control apparatus cuts off the power supply from the safety control apparatus to the main equipment if an abnormality is recognized by the second watchdog control, even if the first watchdog control indicates correct operation.

Abstract: A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases

Abstract: A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases

Abstract: An organism analyzing apparatus includes an information acquiring section configured to acquire an amount of change in a blood glucose level due to ingestion of an organism and a sugar-content estimating section configured to estimate, according to the amount of change in the blood glucose level, sugar content ingested by the organism through the ingestion.

Abstract: In order to provide a prophylactic and/or therapeutic agent for Trk-related diseases, the present invention provides a compound which has a selective Trk-inhibiting activity and persistently inhibits NGF vascular hyper permeability and does not have a drug interaction and in addition thereto, is excellent in solubility and absorbability against free bases. The compound of the present invention has a selective Trk-inhibiting activity and persistently inhibits NGF vascular hyper permeability and does not have a drug interaction and is excellent in solubility and absorbability against free bases, and is therefore useful as a prophylactic and/or therapeutic agent for Trk-related diseases.

Abstract: The present invention provides a drug containing a compound having Trk-inhibiting activity as an active ingredient in prophylaxis and/or therapy for Trk-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease. A compound represented by the general formula (I), wherein all symbols represent the same meanings as described in the specification, a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof is useful as a drug component having Trk-inhibiting activity in prophylaxis and/or therapy of diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease.

Abstract: A wire rope formed from a resin core and six strands, the resin core having an inner core with a circular cross section and an outer layer built up on the periphery thereof. The outer layer has a melting temperature lower than that of the inner core. The six strands are twisted together helically on the periphery of the resin core in an intertwining die in such a state that gaps are assured between the strands. The resulting wire rope is heated in a heating unit at a temperature higher than the melting temperature of the outer layer but lower than the melting temperature of the inner core. The wire rope is formed by subsequently compressing the six strands from the periphery thereof in a compressing die. The molten outer layer is hardened by natural cooling, after which the wire rope is taken up.

Abstract: The present invention provides a drug containing a compound having Trk-inhibiting activity as an active ingredient in prophylaxis and/or therapy for Trk-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease. A compound represented by the general formula (I), wherein all symbols represent the same meanings as described in the specification, a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof is useful as a drug component having Trk-inhibiting activity in prophylaxis and/or therapy of diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease.